Genetically Elevated C-Reactive Protein and Ischemic Vascular Disease
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Elevated levels of C-reactive protein (CRP) are associated with increased risks of ischemic heart disease and ischemic cerebrovascular disease. We tested whether this is a causal association. METHODS: We studied 10,276 persons from a general population cohort, including 1786 in whom ischemic heart disease developed and 741 in whom ischemic cerebrovascular disease developed. We examined another 31,992 persons from a cross-sectional general population study, of whom 2521 had ischemic heart disease and 1483 had ischemic cerebrovascular disease. Finally, we compared 2238 patients with ischemic heart disease with 4474 control subjects and 612 patients with ischemic cerebrovascular disease with 1224 control subjects. We measured levels of high-sensitivity CRP and conducted genotyping for four CRP polymorphisms and two apolipoprotein E polymorphisms. RESULTS: The risk of ischemic heart disease and ischemic cerebrovascular disease was increased by a factor of 1.6 and 1.3, respectively, in persons who had CRP levels above 3 mg per liter, as compared with persons who had CRP levels below 1 mg per liter. Genotype combinations of the four CRP polymorphisms were associated with an increase in CRP levels of up to 64%, resulting in a theoretically predicted increased risk of up to 32% for ischemic heart disease and up to 25% for ischemic cerebrovascular disease. However, these genotype combinations were not associated with an increased risk of ischemic vascular disease. In contrast, apolipoprotein E genotypes were associated with both elevated cholesterol levels and an increased risk of ischemic heart disease. CONCLUSIONS: Polymorphisms in the CRP gene are associated with marked increases in CRP levels and thus with a theoretically predicted increase in the risk of ischemic vascular disease. However, these polymorphisms are not in themselves associated with an increased risk of ischemic vascular disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additional biomarkers, including apo B, lipoprotein(a), high-sensitivity C-reactive protein (CRP), coronary artery calcification score, and ankle-brachial index, are independent risk factors associated with increased risk of ASCVD events and may be helpful when the lipid management goal is unclear.”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [284]
In the citing paper
“The value of hsCRP as a CV risk factor appears similar to that of conventional CV risk factors – hsCRP is not a causal factor for CV disease and serves as a biomarker only [36].”
From Impact of semaglutide on high-sensitivity C-reactive protein: exploratory patient-level analyses of SUSTAIN and PIONEER randomized clinical trials (2022) · cites this paper as [36]
In the citing paper
“PAD is a common manifestation of atherosclerosis and such patients are at elevated risk of coronary events, with PAD representing an independent risk factor for MI and CV death [510,511].”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [511]
In the citing paper
“PAD is a common manifestation of atherosclerosis and such patients are at elevated risk of coronary events, with PAD representing an independent risk factor for MI and CV death [510,511].”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [511]
In the citing paper
“Yet, despite the high CV morbidity and mortality risk, PAD patients are usually inadequately managed compared with CAD patients [511].”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [511]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Davey Smith, G., & Ebrahim, S. (2003) · International Journal of Epidemiology · doi:10.1093/ije/dyg070 · Cited by 5,882
Danesh, J., Wheeler, J. G., Hirschfield, G. M., Eda, S., Eiriksdottir, G., Rumley, A., Lowe, G. D. O., Pepys, M. B., & Gudnason, V. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032804 · Cited by 2,953
Clinical application of C-reactive protein for cardiovascular disease detection and prevention
Ridker, P. M. (2003) · Circulation · doi:10.1161/01.cir.0000053730.47739.3c · Cited by 2,513
Nordestgaard, B. G., Benn, M., Schnohr, P., & Tybjærg-Hansen, A. (2007) · JAMA · doi:10.1001/jama.298.3.299 · Cited by 2,058
Self-citationFasting compared with nonfasting triglycerides and risk of cardiovascular events in women
Bansal, S., Buring, J. E., Rifai, N., Mora, S., Sacks, F. M., & Ridker, P. M. (2007) · JAMA · doi:10.1001/jama.298.3.309 · Cited by 1,619
Newly identified loci that influence lipid concentrations and risk of coronary artery disease
Willer, C. J., Sanna, S., Jackson, A. U., Scuteri, A., Bonnycastle, L. L., Clarke, R., Heath, S. C., Timpson, N. J., Najjar, S. S., Stringham, H. M., et al. (2008) · Nature Genetics · doi:10.1038/ng.76 · Cited by 1,585
Kathiresan, S., Melander, O., Guiducci, C., Surti, A., Burtt, N. P., Rieder, M. J., Cooper, G. M., Roos, C., Voight, B. F., Havulinna, A. S., et al. (2008) · Nature Genetics · doi:10.1038/ng.75 · Cited by 1,386
Mendelian randomization: prospects, potentials, and limitations
Smith, G. D. (2004) · International Journal of Epidemiology · doi:10.1093/ije/dyh132 · Cited by 1,222
Clarke, R., Shipley, M., Lewington, S., Youngman, L., Collins, R., Marmot, M., & Peto, R. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010013 · Cited by 877
Cited by
Items 501–600 of 840
Association study of CRP gene polymorphism and hypertension in Han Chinese population
Zhao, Y., Wang, H., Liu, S., Zhao, X., Yanchun, C., Yang, Y., Wang, W., Yi-ming, W., Chen, A., Tang, J., et al. (2012) · Gene · doi:10.1016/j.gene.2012.09.107 · Cited by 14
Veen, G., Giltay, E. J., van Vliet, I. M., DeRijk, R. H., Klaassens, E. R., PELT, J. V., & Zitman, F. G. (2010) · Stress · doi:10.3109/10253890.2010.515273 · Cited by 14
The connection between type 2 diabetes and erectile dysfunction in Taiwanese aboriginal males
Shi, M., Chao, J.-K., Ma, M.-C., Chiang, S.-K., & Chao, I.-C. (2014) · International Journal of Impotence Research · doi:10.1038/ijir.2014.26 · Cited by 14
Hung, A. M., Ikizler, T. A., Griffin, M. R., Glenn, K., Greevy, R. A., Grijalva, C. G., Siew, E. D., & Crawford, D. C. (2011) · BMC Medical Genetics · doi:10.1186/1471-2350-12-65 · Cited by 14
Freiberg, J., Dahl, M., Tybjærg‐Hansen, A., Grande, P., & Nordestgaard, B. G. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.01.002 · Cited by 14
“Patients with IHD/coronary atherosclerosis were identified among patients from the Copenhagen area referred for coronary angiography because of angina pectoris from 1991 through 2004 [14,15].”
BackgroundSelf-citationC‐reactive protein and incidence of type 2 diabetes in the Pizarra study
Rubio‐Martín, E., Soriguer, F., Gutiérrez‐Repiso, C., Garrido‐Sánchez, L., de Adana, M. R., García‐Fuentes, E., Morcillo, S., Esteva, I., Chaves, F. J., & Rojo‐Martínez, G. (2012) · European Journal of Clinical Investigation · doi:10.1111/eci.12027 · Cited by 14
Yu, Q., Liu, Z., Waqar, A. B., Ning, B., Yang, X., Shiomi, M., Graham, M. J., Crooke, R. M., Liu, E., Dong, S., et al. (2014) · Mediators of Inflammation · doi:10.1155/2014/979132 · Cited by 15
Dekker, M., Waissi, F., Timmerman, N., Silvis, M. J. M., Timmers, L., & de Kleijn, D. P. V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239128 · Cited by 15
C-reactive protein in major depressive disorder: Promise and challenge
Halaris, A. E., Prochaska, D., Stefanski, A., & Filip, M. (2022) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2022.100427 · Cited by 22
Nienhuis, H. L. A., de Leeuw, K., Bijzet, J., van Doormaal, J. J., van Roon, A. M., Smit, A. J., Graaff, R., Kallenberg, C. G. M., & Bijl, M. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3145 · Cited by 14
Ciurtin, C., Helmy, G., Ferreira, A. C., Manson, J. J., Jury, E. C., & McDonnell, T. C. R. (2024) · Clinical Immunology · doi:10.1016/j.clim.2024.110281 · Cited by 14
“However, human data have since refuted these findings questioning whether the association of mCRP with CVD is cause or consequence [14].”
Mendelian Randomisation: Concepts, Opportunities, Challenges, and Future Directions
de Ruiter, S. C., Tschiderer, L., Grobbee, D. E., Willeit, P., den Ruijter, H. M., Schmidt, A. F., & Peters, S. A. E. (2025) · Global Heart · doi:10.5334/gh.1438 · Cited by 17
Chei, C., Yamagishi, K., Ikeda, A., Noda, H., Maruyama, M., Cui, R., Imano, H., Kiyama, M., Kitamura, A., Asada, T., et al. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.07.036 · Cited by 14
Garvik, O. S., Póvoa, P. M. S. R., Magnussen, B., Vinholt, P. J., Pedersen, C. D., Jensen, T. G., Kolmos, H. J., Lassen, A. T., & Gradel, K. O. (2020) · Epidemiology and Infection · doi:10.1017/s0950268820000291 · Cited by 13
“The elevated CRP concentration, >60 mg/l, is much higher than the <10 mg/l found in healthy Danes [13, 14].”
BackgroundSchwaiger, J. P., Kollerits, B., Steinbrenner, I., Weißensteiner, H., Schönherr, S., Forer, L., Kotsis, F., Lamina, C., Schneider, M. P., Schultheiß, U. T., et al. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13437 · Cited by 13
Elosúa, R., Lluís-Ganella, C., & Lucas, G. (2009) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(09)71502-x · Cited by 16
Kim, K. H., Kim, W., Kang, W. Y., Hwang, S. H., Cho, S. C., Kim, W., Jeong, M. H., & Other Korean Working Group in Myocardial Infarction Investigators (2013) · Korean Circulation Journal · doi:10.4070/kcj.2013.43.10.664 · Cited by 15
Screening for heart disease: C-reactive protein versus coronary artery calcium
Patel, A., & Budoff, M. J. (2009) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.09.166 · Cited by 13
Lipoprotein(a) Should be Taken Much More Seriously
Kamstrup, P. R., & Nordestgaard, B. G. (2009) · Biomarkers in Medicine · doi:10.2217/bmm.09.57 · Cited by 13
Self-citationSiggaard-Andersen, N., Freiberg, J., & Nordestgaard, B. G. (2012) · PubMed · Cited by 13
Self-citationAtherosclerosis, its risk factors, and cognitive impairment in older adults.
Xing, Y., Chen, M. A., Sun, Y., Neradilek, M. B., Wu, X.-T., Zhang, D., Huang, W., Cui, Y., Yang, Q., Li, H., et al. (2020) · PubMed Central · doi:10.11909/j.issn.1671-5411.2020.07.006 · Cited by 16
Rosendo, A. B., Lima, L. O., Dal‐Pizzol, F., & Almeida, S. (2010) · Inflammation · doi:10.1007/s10753-009-9178-3 · Cited by 13
Pretenders and Contenders: Inflammation, C‐Reactive Protein, and Interleukin‐6
Daniels, L. B. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.007490 · Cited by 14
Inoue, T., Doi, T., Beppu, K., Sasaki, Y., Takeda, S., Watanabe, C., Shirasaka, A., Kakio, T., Hashimoto, T., Kawai, C., et al. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.01.044 · Cited by 13
deGoma, E. M., Walsh, J., & Georgakis, M. K. (2025) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.125.005103 · Cited by 17
Leiherer, A., Muendlein, A., Brandtner, E. M., Säly, C., Ramadani, H., Vonbank, A., MADER, A., Dopheide, J. F., Jylhä, A., Lääperi, M., et al. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13368 · Cited by 12
Meulenbelt, I., Bos, S. D., Kloppenburg, M., Lakenberg, N., Houwing‐Duistermaat, J. J., Watt, I., de Craen, A. J. M., van Duijn, C. M., & Slagboom, P. E. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27325 · Cited by 14
Recurrent mutations at C-reactive protein gene promoter SNP position −286 in human cancers
Wang, M., Zhou, H., Zhang, S., Hui, F., Zhu, W., Su, H., Guo, H., Li, X.-W., Ji, S., & Wu, Y. (2014) · Cell Research · doi:10.1038/cr.2014.7 · Cited by 12
Johannesen, J., Svensson, J., Bergholdt, R., Eising, S., Gramstrup, H. M., Frandsen, E., Dick-Nielsen, J., Hansen, L., Pociot, F., Mortensen, H. B., et al. (2010) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2010.00660.x · Cited by 12
Ibáñez, L., Velli, P., Font, R., Jaén, Á., Royo, J., Irigoyen, D., Cairó, M., de la Sierra, A., Arranz, M. J., Gallardo, D., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112279 · Cited by 12
Zacho, J., Tybjærg‐Hansen, A., & Nordestgaard, B. G. (2009) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510903056015 · Cited by 12
Self-citationGenetic Variation in GSTP1, Lung Function, Risk of Lung Cancer, and Mortality
Nørskov, M. S., Dahl, M., & Tybjærg‐Hansen, A. (2017) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2017.07.008 · Cited by 12
Self-citationMendelian randomization: a premature burial?Preprint
Smith, G. D. (2015) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/021386 · Cited by 12
Nakada, S., Celis-Morales, C. A., Pell, J. P., & Ho, F. K. W. (2025) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaf110 · Cited by 13
Freiberg, J., Tybjærg–Hansen, A., & Nordestgaard, B. G. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.03903.x · Cited by 11
Self-citationKarabay, E. A., Çerman, A. A., & Altunay, İ. K. (2016) · Turkiye Klinikleri Journal of Dermatology · doi:10.5336/dermato.2016-52709 · Cited by 11
Increased Serum C-reactive Protein and Corpus Callosum Alterations in Older Adults
Cyprien, F., Courtet, P., Maller, J. J., Meslin, C., Ritchie, K. A., Ancelin, M., & Artéro, S. (2018) · Aging and Disease · doi:10.14336/ad.2018.0329 · Cited by 12
Yazdanyar, S., & Nordestgaard, B. G. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02232.x · Cited by 11
Self-citationSeverino, A., Zara, C., Campioni, M., Flego, D., Angelini, G., Pedicino, D., Giglio, A. F., Trotta, F., Giubilato, S., Pazzano, V., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15420 · Cited by 11
Tony, A. A., Tony, E. A. E., Salah, W. M., & Kholef, E. F. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s177726 · Cited by 11
McPherson, R. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.311392 · Cited by 12
Blood biomarker levels by total sleep duration: cross-sectional analyses in UK Biobank
Wong, T. Y., Travis, R. C., & Tong, T. Y. N. (2021) · Sleep Medicine · doi:10.1016/j.sleep.2021.10.018 · Cited by 11
Expanded Network of Inflammatory Markers of Atherogenesis: Where Are We Now?
Abbasi, S. H., & Boroumand, M. A. (2010) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401004010038 · Cited by 17
Celada, P., Sánchez-Muniz, F. J., Delgado‐Pando, G., Bastida, S., Rodilla, M. E., Jiménez-Colmenero, F., & Olmedilla‐Alonso, B. (2016) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-016-0505-5 · Cited by 11
Twenty years of genome-wide association studies: Health translation challenges and AI opportunities
Huang, J., McLean, G. R., & Franke, A. (2025) · European Journal of Human Genetics · doi:10.1038/s41431-025-01951-5 · Cited by 11
Blyme, A., Asferg, C. L., Nielsen, O. W., Sehestedt, T. B., Kesäniemi, Y. A., Gohlke-Bärwolf, C., Boman, K., Willenheimer, R. B., Ray, S. G., Nienaber, C. A., et al. (2015) · Open Heart · doi:10.1136/openhrt-2014-000152 · Cited by 10
Kyhl, L. K., Nordestgaard, B. G., Tybjærg‐Hansen, A., & Nielsen, S. F. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.05.015 · Cited by 10
Self-citationZhao, S. S., & Burgess, S. (2024) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2024.101967 · Cited by 12
“For example, MR studies of CRP contributed to its de-prioritisation as a therapeutic target for cardiovascular disease [45].”
BackgroundResultMetabolomics: On the way to an integration of biochemistry, analytical chemistry, and informatics
Goncharov, N., Ukolov, A., Орлова, Т. Ю., Migalovskaia, E. D., & Voitenko, N. (2015) · Biology Bulletin Reviews · doi:10.1134/s2079086415040027 · Cited by 10
Ling, Y., Li, X., & Gao, X. (2013) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20131485 · Cited by 11
“However, the CRP polymorphisms are not in themselves associated with an increased risk of ischemic vascular disease.(40) More interestingly, studies examining the association of CRP polymorphisms with CKD found that CRP variant associated with concentrations of CRP did not predict CKD progression, while CRP variant pr…”
BackgroundAcute Phase Reactants and the Concept of Inflammation
Saxena, A., & Cronstein, B. N. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4377-1738-9.00057-8 · Cited by 16
Creating a genetic risk score for coronary artery disease
Dandona, S., & Roberts, R. (2009) · Current Atherosclerosis Reports · doi:10.1007/s11883-009-0028-4 · Cited by 10
“There are three common variants of apoE: -2, -3, and -4. The apoE-4 variant, characterized by the substitution of arginine for cysteine at residue 112 [6], has been associated with CAD [ 7 ].”
BackgroundInflammation and Atherosclerosis: Disease Modulating Therapies
Patel, M. J., & Blazing, M. A. (2013) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-013-0268-z · Cited by 11
Brito, V., Alcaraz, A. O., Augustovski, F., Pichón-Rivière, A., Martí, S. G., Bardach, A., Ciapponi, A., López, A., & Comandé, D. (2015) · Archivos de cardiología de México · doi:10.1016/j.acmx.2014.11.005 · Cited by 15
C-Reactive Protein as a Prognostic Indicator in COVID-19 mild infection Patients
Alabd, S., & Yameny, A. A. (2021) · Journal of Medical and Life Science · doi:10.21608/jmals.2021.240126 · Cited by 11
Lund, K. P., von Stemann, J. H., Eriksson, F., Hansen, M. B., Pedersen, B. K., Sørensen, S. S., & Brüünsgaard, H. (2019) · Transplant International · doi:10.1111/tri.13425 · Cited by 11
“Most epidemiological studies, however, focus on CRP and IL-6 as biomarkers of chronic inflammation, although cytokines such as IL-10, TNF-a, and IL-1 could be more important from a pathophysiological point of view [27].”
BackgroundErayman, A., & Şen, N. (2013) · Angiology · doi:10.1177/0003319713502719 · Cited by 10
Jeppesen, J. (2011) · The Journal of Rheumatology · doi:10.3899/jrheum.110006 · Cited by 10
What is the role of alternative biomarkers for coronary heart disease?
Garg, A. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04045.x · Cited by 11
C-Reactive Protein and Inflammatory Cytokines during Percutaneous Coronary Intervention
Wu, M., Gu, X., Li, X., Li, Y., Zhou, H., Lu, G., Wu, Z., Huang, H., Tang, L., & Zeng, J. (2016) · Journal of Vascular Research · doi:10.1159/000447558 · Cited by 9
Hong, S., Kim, J., Bae, H. J., & Kim, W. Y. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.662510 · Cited by 9
“Elevated CRP is associated with the development of inflammation, atherosclerosis, and relevant disorders (10).”
BackgroundInfections and inflammation in the development of stroke
Samoilova, E. M., Yusubalieva, G. M., Викторович, Б. В., Ekusheva, E. V., & Baklaushev, V. P. (2021) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202112108211 · Cited by 11
Schulz, S., Rehm, S., Schlitt, A., Lierath, M., Lüdike, H., Hofmann, B., Bitter, K., & Reichert, S. (2023) · Cells · doi:10.3390/cells12131775 · Cited by 10
“SNPs associated with elevated CRP levels consequently may be accompanied by an increase in CVD risk [24].”
BackgroundSato, A., Nakashima, H., Kinoshita, M., Nakashima, M., Ogawa, Y., Shono, S., Ikarashi, M., & Seki, S. (2013) · Inflammation · doi:10.1007/s10753-013-9604-4 · Cited by 10
Nair, A. M., Goel, R., Hindhumati, M., Shah, K., Chandana, P., Jayaseelan, V., Kabeerdoss, J., Joseph, G., Danda, S., & Danda, D. (2017) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.13180 · Cited by 9
Vedel‐Krogh, S., Nielsen, S. F., Schnohr, P., & Nordestgaard, B. G. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151636 · Cited by 10
Self-citationGenetics of Coronary Atherosclerosis
Aragam, K. G., & Kathiresan, S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-42880-4.00003-0 · Cited by 9
Vasan, R. S. (2009) · International Journal of Epidemiology · doi:10.1093/ije/dyn353 · Cited by 9
Rai, H., Reddi, R., Coughlan, J. J., Durand, R., O’Callaghan, D., Colleran, R., & Byrne, R. A. (2025) · Health Science Reports · doi:10.1002/hsr2.70757 · Cited by 8
“2, in the long arm of chromosome 1, has been shown to genetically determine a marked increase in CRP levels [56].”
Rolver, M. G., Emanuelsson, F., Nordestgaard, B. G., & Benn, M. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-03028-5 · Cited by 8
Self-citationAlghadir, A. H., Gabr, S. A., Al-Momani, M. O., Almomani, F., & Tse, C. M. (2022) · Pain Research and Management · doi:10.1155/2022/7480579 · Cited by 8
Ahmed, H. A., Jeilan, M., Akuku, I. G., Lee, K. K., Alam, S. R., Perel, P., Shah, J., Ali, M. K., Eskander, S., Chung, M. H., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-062352 · Cited by 9
Wang, Y., Fu, J., Liang, F., Oniffrey, T. M., Ding, K., Zeng, J., Moore, J. B., Luo, X., & Li, R. (2023) · Brain Sciences · doi:10.3390/brainsci13040658 · Cited by 8
“Emerging evidence demonstrates that elevated Hs-CRP may be an important marker of schizophrenia [49], cerebrovascular disease [50], and stroke [51].”
BackgroundBahrami, H. S. Z., Jørgensen, P. G., Hove, J. D., Dixen, U., Rasmussen, L. J. H., Eugen‐Olsen, J., Rossing, P. R., & Jensen, M. T. (2025) · Journal of Internal Medicine · doi:10.1111/joim.20108 · Cited by 9
Inflammation as a target for improving health in chronic kidney disease
Stenvinkel, P. (2010) · F1000 Medicine Reports · doi:10.3410/m2-88 · Cited by 8
Assessment of Cardiac Risk in Women with Autoimmune Disease
Schmidt, T. J., & Mankad, R. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01698-1 · Cited by 8
Interleukin-6 Signaling in Atherosclerosis: From Molecular Mechanisms To Clinical Outcomes
Papastamos, C., Antonopoulos, A. S., Simantiris, S., Κούμαλλος, Ν., Sagris, Μ., Theofilis, P., Oikonomou, E. K., Siasos, G., Tsioufis, K. P., & Tousoulis, D. (2023) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026623666230718141235 · Cited by 11
Scientific Contributions of Population-Based Studies to Cardiovascular Epidemiology in the GWAS Era
Lieb, W., & Vasan, R. S. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00057 · Cited by 8
“Using MR analyses in population-based samples, several traits along the CVD continuum and biomarkers have been tested for potentially causal relations with incident CVD, including high-density lipoprotein (HDL) cholesterol (53), C-reactive protein (56), lipoprotein(a) (57), and many others.”
MethodYao, Z., Zhang, Y., Potempa, L. A., Rajab, I. M., Ji, L., Lv, J., Liu, S., Zhang, L., & Wu, H. (2019) · Journal of Immunological Methods · doi:10.1016/j.jim.2019.04.009 · Cited by 8
Pentraxins: The L-Type Lectins and the C-Reactive Protein as a Cardiovascular Risk
Gupta, G. (2012) · Springer eBooks · doi:10.1007/978-3-7091-1065-2_8 · Cited by 8
Stender, S., Frikke‐Schmidt, R., Anestis, A., Kardassis, D., Sethi, A. A., Nordestgaard, B. G., & Tybjærg‐Hansen, A. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.223867 · Cited by 9
Self-citationThe importance of HDL-C and CRP in cardiovascular risk evaluation in longevous elderly individuals
Laks, R., Araújo, L. M. Q., Filho, C. D. M. A., & Cendoroglo, M. S. (2011) · Einstein (São Paulo) · doi:10.1590/s1679-45082011rw1953 · Cited by 9
Sanz, J., Moreno, P., & Fuster, V. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.12.047 · Cited by 10
Genetically Elevated C-Reactive Protein and Vascular Disease
Harbord, R. M., Lawlor, D. A., & Smith, G. D. (2009) · New England Journal of Medicine · doi:10.1056/nejmc082413 · Cited by 8
JUPITER: major implications for vascular risk assessment
Τζιόμαλος, Κ., Athyros, V. G., Karagiannis, A. I., & Mikhailidis, D. P. (2008) · Current Medical Research and Opinion · doi:10.1185/03007990802643557 · Cited by 8
Metabolic Syndrome and its Impact on Cardiovascular Diseases
Edla, N. K. J. P. S. (2014) · Journal of Metabolic Syndrome · doi:10.4172/2167-0943.1000142 · Cited by 8
Ali, N., Debernardi, S., Kurotova, E., Tajbakhsh, J., Gupta, N. K., Pandol, S. J., Wilson, P., Pereira, S. P., Greenhalf, B., Blyuss, O. B., et al. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1450326 · Cited by 7
Frikke‐Schmidt, R., Tybjærg‐Hansen, A., Dyson, G. E., Haase, C. L., Benn, M., Nordestgaard, B. G., & Sing, C. F. (2014) · International Journal of Epidemiology · doi:10.1093/ije/dyu215 · Cited by 7
Self-citationEvidence-Based Approach in Translational Dental Research
Janket, S., Nunn, M. E., Salih, E., & Baird, A. E. (2018) · Springer eBooks · doi:10.1007/978-3-319-78205-8_8 · Cited by 8
Do Elevated Serum C-Reactive-Protein Levels Excuse Delayed Surgery for Femoral Neck Fractures?
Laggner, R., Taner, B., Straub, J., Tiefenboeck, T. M., Binder, H., Sator, T., Hajdú, Š., Windhager, R., & Böhler, C. (2023) · Antibiotics · doi:10.3390/antibiotics12040738 · Cited by 8
COVID-19 Laboratory diagnosis methods
Yameny, A. A. (2023) · Journal of Bioscience and Applied Research/Journal of Bioscience and Applied Research · doi:10.21608/jbaar.2023.311827 · Cited by 7
Unraveling New Therapeutic Targets of Coronary Artery Disease by Genetic Approaches
Lee, S. E., & Kim, H.-S. (2014) · Circulation Journal · doi:10.1253/circj.cj-14-0985 · Cited by 7
Stewart, R. (2009) · Future Cardiology · doi:10.2217/fca.09.8 · Cited by 7
Defining a Contemporary Ischemic Heart Disease Genetic Risk Profile Using Historical Data
Mosley, J. D., Driest, S. L. V., Wells, Q. S., Shaffer, C. M., Edwards, T. L., Bastarache, L. A., McCarty, C. A., Thompson, W. K., Chute, C. G., Jarvik, G. P., et al. (2016) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.116.001530 · Cited by 8
Huang, Y., Zhou, H., Wu, Y., Yang, Y., Li, W., Lu, J., & Hu, Y. (2017) · Disease Markers · doi:10.1155/2017/4719403 · Cited by 9
Association between CRP genetic diversity and bipolar disorder comorbid complications
Boukouaci, W., Oliveira, J., Étain, B., Bennabi, M., Mariaselvam, C. M., Hamdani, N., Manier, C., Bengoufa, D., Bellivier, F., Henry, C., et al. (2018) · International Journal of Bipolar Disorders · doi:10.1186/s40345-017-0109-1 · Cited by 7
Евстифеева, С. Е., Shalnova, S. A., Deev, А. D., Гатагонова, Т. М., Efanov, А. Y., Zhernakova, Y. V., IL'IN, V. A., Конради, А. О., Metelskaya, V. A., Oschchepkova, E. V., et al. (2014) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2014-10-6-597-605 · Cited by 7
Bioinformatics analysis of the circRNA-miRNA-mRNA network for atrial fibrillation
Liu, X., Zeng, Y., Liu, Z., Li, W., Wang, L., & Wu, M. (2022) · Medicine · doi:10.1097/md.0000000000030221 · Cited by 8
“[28,29] Thus, further exploration of the molecular mechanism of atrial fibrosis might be a potential means of preventing and treating AF.”
BackgroundRadiation Dose in Cardiac Imaging: How Should It Affect Clinical Decisions?
Shapiro, B. P., Mergo, P. J., Snipelisky, D., Kantor, B., & Gerber, T. C. (2013) · American Journal of Roentgenology · doi:10.2214/ajr.12.9773 · Cited by 8
“Recently, elevated C-reactive protein has shown promise in early detection of atherosclerotic disease [4] and may be a useful adjunct to guide therapeutic targets with statin therapy [5].”
BackgroundYaldız, M., & Asil, K. (2019) · Advances in Dermatology and Allergology · doi:10.5114/ada.2018.79567 · Cited by 7
Metadata
- Authors
- Zacho, J., Tybjærg-Hansen, A., Jensen, J. S., Grande, P., Sillesen, H., & Nordestgaard, B. G.
- Affiliations
- University of Copenhagen (DK)
- Herlev Hospital (DK)
- Rigshospitalet (DK)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2008-10-30
- Volume
- 359
- Issue
- 18
- Pages
- 1897-1908
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2081615427
- Cited by
- 839
- References
- 36
- Citations by year
- 2026: 22 · 2025: 21 · 2024: 21 · 2023: 21 · 2022: 26 · 2021: 25 · 2020: 33 · 2019: 25 · 2018: 28 · 2017: 40 · 2016: 48 · 2015: 44 · 2014: 61 · 2013: 56 · 2012: 76
- FWCI
- 102.24
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Immunology and Microbiology › Immunology › Biomarkers in Disease Mechanisms
- Keywords
- C-reactive protein, ischemic heart disease, ischemic cerebrovascular disease, ischemic vascular disease, CRP gene polymorphisms, apolipoprotein E, high-sensitivity CRP, genetic association, cholesterol levels, causal relationship
- MeSH terms
- C-Reactive Protein, Cerebrovascular Disorders, Cross-Sectional Studies, Female, Humans, Male, Polymorphism, Genetic, Risk Factors, Cohort Studies, Biomarkers, Myocardial Ischemia, Genetic Predisposition to Disease, Atherosclerosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.